信邦制药：公司拥有11个国家基药目录品种，23个国家医保目录品种

Core Viewpoint - The company, Xinbang Pharmaceutical, has a strong portfolio in traditional Chinese medicine, with multiple products listed in national essential drug and medical insurance directories, indicating a solid market position and potential for growth [2] Group 1: Product Portfolio - As of the fiscal year 2024, the company has 11 products listed in the national essential drug directory [2] - The company has 23 products included in the national medical insurance directory [2] - Key products such as Yixinshu Capsules, Maixuekang Capsules, and Guanjie Kebing Pills are among those listed in the national medical insurance directory, highlighting their significance in the company's offerings [2]